U.S. markets open in 7 hours 39 minutes
  • S&P Futures

    3,822.50
    -26.00 (-0.68%)
     
  • Dow Futures

    30,671.00
    -197.00 (-0.64%)
     
  • Nasdaq Futures

    13,393.25
    -82.25 (-0.61%)
     
  • Russell 2000 Futures

    2,139.40
    -21.60 (-1.00%)
     
  • Crude Oil

    52.34
    -0.43 (-0.81%)
     
  • Gold

    1,853.70
    -1.50 (-0.08%)
     
  • Silver

    25.31
    -0.17 (-0.68%)
     
  • EUR/USD

    1.2133
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.0400
    0.0000 (0.00%)
     
  • Vix

    23.19
    +1.28 (+5.84%)
     
  • GBP/USD

    1.3642
    -0.0034 (-0.25%)
     
  • USD/JPY

    103.7110
    -0.0450 (-0.04%)
     
  • BTC-USD

    31,650.13
    -718.15 (-2.22%)
     
  • CMC Crypto 200

    640.29
    -36.61 (-5.41%)
     
  • FTSE 100

    6,638.85
    -56.22 (-0.84%)
     
  • Nikkei 225

    28,546.18
    -276.11 (-0.96%)
     

CLASS ACTION UPDATE for VERB, CURLF and ABMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 30, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Verb Technology Company, Inc. (f/k/a nFüsz, Inc.) (VERB)

Lawsuit on behalf of: investors who purchased January 3, 2018 - May 2, 2018
Lead Plaintiff Deadline : September 9, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/verb-technology-company-inc-f-k-a-nfusz-inc-fusz-loss-form?prid=3273&wire=1

The filed complaint alleges that Verb Technology Company, Inc. (f/k/a nFüsz, Inc.) violated federal securities laws by issuing materially false and/or misleading information and/or failing to disclose material information. Specifically, Defendants made false and/or misleading statements as to the scope of the Agreement with Oracle as the Company did not have a contract with Oracle to jointly develop and market the Company’s product and that as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

Curaleaf Holdings, Inc. (CURLF)

Lawsuit on behalf of: investors who purchased November 21, 2018 - July 22, 2019
Lead Plaintiff Deadline : October 4, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/curaleaf-holdings-inc-loss-form?prid=3273&wire=1

According to the filed complaint, during the class period, Curaleaf Holdings, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Abiomed, Inc. (ABMD)

Lawsuit on behalf of: investors who purchased January 31, 2019 - July 31, 2019
Lead Plaintiff Deadline : October 7, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/abiomed-inc-loss-form?prid=3273&wire=1

According to the filed complaint, during the class period, Abiomed, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/558010/CLASS-ACTION-UPDATE-for-VERB-CURLF-and-ABMD-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders